# Avatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure Disease

> **NCT05823376** · — · RECRUITING · sponsor: **Anhui Provincial Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Platelet Recovery After Umbilical Cord Blood Transplantation

## Interventions

- **DRUG:** Avatrombopag

## Key facts

- **NCT ID:** NCT05823376
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-04
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-02-28
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05823376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05823376, "Avatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure Disease". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05823376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*